T1 mapping定量分析肝细胞特异性对比剂MRI对局灶性肝脏病变的鉴别诊断
结果显示仅LRI在四类病变间有显著差异(p<0.01),ΔT1与SIR无显著差异;LRI在结直肠转移瘤与血管瘤、血管瘤与肝内胆管癌、肝细胞癌与肝内胆管癌之间均有显著差异。结论认为T1 mapping估算的瘤内钆塞酸滞留量可鉴别局灶性肝脏病变,而常规处理方法不能。
要点
- LRI在结直肠转移瘤、肝细胞癌、血管瘤、肝内胆管癌四类病变间有显著差异(p<0.01)。
- 常规SIR与ΔT1在四类病变间无显著差异,鉴别价值有限。
- LRI在CRM vs 血管瘤、血管瘤 vs ICC、HCC vs ICC间有显著差异。
关键影像表现/征象
- 四类病变的LRI存在显著差异(p<0.01),而ΔT1和SIR无显著差异。
- LRI在CRM与血管瘤间有显著差异(p<0.01)。
- LRI在血管瘤与ICC间有显著差异(p<0.01)。
- LRI在HCC与ICC间有显著差异(p=0.047)。
诊断标准与关键数值
- LRI(病灶滞留指数,%)基于增强前后T1 mapping采用两室药代动力学模型计算,四类病变间有显著差异(p<0.01)。
- ΔT1(增强前后病灶T1值差值,ms)在四类病变间无显著差异。
- SIR(病灶-肝脏信号强度比)在四类病变间无显著差异。
临床应用与阅片要点
- 日常阅片可尝试基于增强前后T1 mapping计算LRI,辅助鉴别肝脏局灶性病变。
- 常规SIR和ΔT1对四类病变的鉴别价值有限,不宜单独依赖。
- LRI在HCC与ICC、血管瘤与ICC、CRM与血管瘤间有显著差异,可结合临床使用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the estimated quantity of intratumor gadoxetic acid retention using T1 mapping of gadoxetic acid-enhanced magnetic resonance imaging (MRI) versus conventional processing methods for the differential diagnosis of focal liver lesions.
METHODS: Seventy patients with hepatic lesions (colorectal metastasis (CRM) [n = 28], hepatocellular carcinoma (HCC) [n = 20], hemangioma [n = 12], and intrahepatic cholangiocarcinoma (ICC) [n = 10]) underwent gadoxetic acid-enhanced MRI, including pre- and post-contrast T1-weighted imaging and T1 mapping. Quantitative analyses included the lesion-to-liver signal intensity ratio (SIR) on hepatobiliary phase images, the pre- and post-contrast lesion T1 value difference (ΔT1 [ms]), and the lesion retention index (LRI [%]), which was the estimated intralesional gadoxetic acid retention calculated on pre- and post-contrast T1 maps using a two-compartment pharmacokinetic model. Results were compared between the four subcategories of focal liver lesions using the Kruskal-Wallis test, followed by the post-hoc Dunn's test and receiver operating characteristic (ROC) analysis to distinguish between pairs of the four lesion subcategories.
RESULTS: This study identified significant differences in the LRI of the four lesion subcategories (p < 0.01), without significant differences in ΔT1 or SIR. Post-hoc analysis demonstrated significant differences in CRM vs. hemangioma (p < 0.01), hemangioma vs. ICC (p < 0.01), and HCC vs. ICC (p = 0.047) for the LRI.
CONCLUSIONS: The quantity of intratumor gadoxetic acid retention estimated using pre- and post- contrast T1 mapping could distinguish focal liver lesions, unlike conventional processing methods, and captured unique lesion characteristics.
引用
- Morisaka H, Seno D, Sakurai Y, et al. Quantitative analysis of gadoxetic acid-enhanced MRI for the differential diagnosis of focal liver lesions: Comparison between estimated intralesional gadoxetic acid retention by T1 mapping and conventional processing methods. Eur J Radiol. 2021. PMID: 33713905. doi:10.1016/j.ejrad.2021.109620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。